CytomX Therapeutics, Inc. (CTMX)
NASDAQ: CTMX · Real-Time Price · USD
2.040
0.00 (0.00%)
At close: Nov 13, 2026, 4:00 PM EST
2.040
0.00 (0.00%)
Pre-market: Nov 16, 2026, 4:03 AM EST

CytomX Therapeutics Revenue

CytomX Therapeutics had revenue of $1.69M in the quarter ending September 30, 2026, a decrease of -71.69%. This brings the company's total for the last twelve months to $14.03M, down -87.66% year-over-year. In the year 2025, CytomX Therapeutics had annual revenue of $76.20M, down -44.82%. That makes CytomX Therapeutics the 35,781st largest company in the world by revenue and 4,701st in the United States.

Revenue (ttm)
$14.03M
Revenue Growth
-87.66%
P/S Ratio
31.70
Revenue / Employee
$203,304
Employees
69
Market Cap
444.73M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202576.20M-61.90M-44.82%
Dec 31, 2024138.10M36.89M36.45%
Dec 31, 2023101.21M48.05M90.38%
Dec 31, 202253.16M-16.41M-23.59%
Dec 31, 202169.57M1.15M1.67%
Dec 31, 202068.43M41.53M154.36%
Dec 31, 201926.90M-32.60M-54.79%
Dec 31, 201859.50M-12.12M-16.92%
Dec 31, 201771.62M58.78M457.59%
Dec 31, 201612.85M6.90M116.21%
Dec 31, 20155.94M--
Dec 31, 2014---
Dec 31, 2013888.00K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.